Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 5a8y.1

Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.90 Å
Oligo State
monomer
Ligands
1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x VBM: METHYL {(7R)-6-CYANO-7-(4-CYANOPHENYL)-5-METHYL-4-[3-(TRIFLUOROMETHYL)PHENYL]-4,7-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-2-YL}CARBAMATE(Non-covalent)
1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
1 x MLI: MALONATE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Von Nussbaum, F. et al., Potent and Selective Human Neutrophil Elastase Inhibitors with Novel Equatorial Ring Topology: In Vivo Efficacy of the Polar Pyrimidopyridazine Bay-8040 in a Pulmonary Arterial Hypertension Rat Model. Chemmedchem (2016)
Release Date
2016-08-03
Peptides
NEUTROPHIL ELASTASE: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A